Cita APA

Sousa-Herves, A., Arminan, A., Charbonnier, D., Arroyo-Crespo, J., Wedepohl, S., Calderon, M., & Vicent, M. (2021). Polyglutamic acid-based crosslinked doxorubicin nanogels as an anti-metastatic treatment for triple negative breast cancer.

Citación estilo Chicago

Sousa-Herves, A., A. Arminan, D. Charbonnier, JJ Arroyo-Crespo, S. Wedepohl, M. Calderon, y MJ Vicent. Polyglutamic Acid-based Crosslinked Doxorubicin Nanogels As an Anti-metastatic Treatment for Triple Negative Breast Cancer. 2021.

Cita MLA

Sousa-Herves, A., et al. Polyglutamic Acid-based Crosslinked Doxorubicin Nanogels As an Anti-metastatic Treatment for Triple Negative Breast Cancer. 2021.